Illumina Inc (NASDAQ:ILMN)

CAPS Rating: 3 out of 5

The Company is a developer, manufacturer and marketer of next-generation life-science tools and integrated systems for the analysis of genetic variation and biological function.

Recs

0
Player Avatar bclan13 (99.07) Submitted: 1/18/2013 4:03:09 PM : Underperform Start Price: $50.95 ILMN Score: +2.37

Overvalued in this funding environment. And all the value in complex diagnostics is being gobbled up by labs not hardware companies.

Featured Broker Partners


Advertisement